ANSIRH in the News Media Inquires Virali Modi-ParekhStrategic Communications Director(415) 353-4784[email protected] May 4, 2023 Birth control pills aren’t available over the counter in U.S. That could change. The Washington Post May 2, 2023 UW Medicine works to fill national gap in abortion care training Komo News May 2, 2023 Reproductive health care bill passes Oregon House, despite Republican delay tactics OPB April 28, 2023 New study suggests many are crossing state lines for abortion access KUNC/NPR for Northern Colorado April 23, 2023 How the latest wave of abortion bans could deepen the wealth gap and make inequality worse Fast Company April 21, 2023 Pill restrictions would upend nascent telehealth abortion industry Politico April 20, 2023 One drug medication abortion with misoprostol grows in US Reuters April 19, 2023 As Legal Future of Abortion Pill Hangs in Balance, Virtual Clinics Remain Widely Used KQED April 18, 2023 Mifepristone 'safer than Tylenol,' experts say amid court battle over major abortion pill USA Today April 18, 2023 Health Care Without Mifepristone? “The Experience for Patients Is Going to Be Awful.” Mother Jones April 17, 2023 Study reveals bias in drug testing pregnant patients Axios April 16, 2023 How the courts could limit access to mifepristone without banning it outright National Journal More
May 4, 2023 Birth control pills aren’t available over the counter in U.S. That could change. The Washington Post
April 28, 2023 New study suggests many are crossing state lines for abortion access KUNC/NPR for Northern Colorado
April 23, 2023 How the latest wave of abortion bans could deepen the wealth gap and make inequality worse Fast Company
April 19, 2023 As Legal Future of Abortion Pill Hangs in Balance, Virtual Clinics Remain Widely Used KQED
April 18, 2023 Mifepristone 'safer than Tylenol,' experts say amid court battle over major abortion pill USA Today
April 18, 2023 Health Care Without Mifepristone? “The Experience for Patients Is Going to Be Awful.” Mother Jones
April 16, 2023 How the courts could limit access to mifepristone without banning it outright National Journal